US Stock MarketDetailed Quotes

COEPW COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM)

Watchlist
  • 0.034
  • -0.001-2.88%
Close Nov 5 16:00 ET
0.034High0.026Low

About COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) Company

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.

Company Profile

SymbolCOEPW
Company NameCOEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM)
Listing DateDec 17, 2020
Founded2017
CEOMr. David Mehalick
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address105 Bradford Road,Suite 420
CityWexford
ProvincePennsylvania
CountryUnited States of America
Zip Code15090
Phone1-724-934-6467
Websitehttp://www.coeptistx.com

Company Executives

  • Name
  • Position
  • Salary
  • David Mehalick
  • Chairman of the Board, President and Chief Executive Officer
  • 18.33K
  • Brian Cogley
  • Chief Financial Officer
  • 208.00K
  • Dr. Colleen Delaney, M.D.
  • Chief Scientific and Medical Officer
  • 360.00K
  • Christine Sheehy
  • Vice President, Compliance and Corporate Secretary
  • 151.00K
  • Daniel Yerace
  • Director and Vice President of Operations
  • 18.33K
  • Christopher Calise
  • Director
  • 18.33K
  • Dr. Gene Salkind, M.D.
  • Independent Director
  • 18.33K
  • Philippe Deschamps
  • Independent Director
  • 18.33K
  • Christopher Cochran
  • Independent Director
  • 18.33K
  • Dr. Tara Maria DeSilva
  • Independent Director
  • 18.33K